Deals
BC Partners to Bridgepoint Said Among Bidders to Acquire Cooper
- Charterhouse also interested in buying French pharmacy firm
- Sale may be agreed by year-end, could fetch 700 million euros
This article is for subscribers only.
Buyout firms BC Partners, Bridgepoint and Charterhouse Capital Partners are among bidders competing to buy French pharmaceutical company Cooper, according to people with knowledge of the matter.
The sale process is at an advanced stage and may be agreed as early as year-end, the people said, asking not to be identified because the negotiations are private. While the sale of Melun, France-based Cooper has mainly attracted interest from private-equity firms, some strategic buyers may also be interested, the people said. No final decision has been made, and French buyout firm Caravelle may choose not to sell the company, they said.